Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Native Chemical Ligation . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN121517536A reveals high-purity Semaglutide synthesis. Achieve significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Discover the novel hydrazide-based synthesis of Pramlintide (CN111499719B). High-purity API intermediate manufacturing with optimized fragment coupling and scalable oxidation processes.
Patent CN114685645A details a novel Semaglutide synthesis using NCL and desulfurization, offering improved purity and cost reduction for API manufacturing.
Patent CN114685645B reveals a novel native chemical ligation method for semaglutide, offering significant cost reduction in peptide manufacturing and enhanced supply chain reliability for global buyers.